Taho
$3.5Mlatest round · Convertible Note · Aug 2024 · 2 yr ago
7team · US Form 5500 (plan participants) · Dec 2025
2024founded
13stories in the press
Overview
Taho is the first web3 wallet built by and for the community. We're 100% open source, all in-wallet revenue flows back to users, and, unlike other crypto wallets, we never limit access to your assets, no matter where you live.
Funding and backers
Total raised
$3.5M
1 round on record
Latest round
$3.5M
Convertible Note · Aug 2024 · 2 yr ago
Team
7
US Form 5500 (plan participants) · Dec 2025
The money's age
Long since its last round
27 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Tractionpublic signals, read monthly
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Convertible Note | Aug 2024 | $3.5M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | TAHO, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Todd SmithExecutive Officer, DirectorSEC Form D
Justin GelinasExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
MetaStreet creates yield products from any asset, no matter how illiquid.
Your favorite crypto wallet.. Explore Ethereum with the best wallet for iOS. Interacting with crypto has never been so simple.
Run open-source AI, privately.. We run open-source AI models for you in private, secure datacenters. We never train on your data, and we…
Kresus Labs builds enterprise blockchain infrastructure (wallets, tokenization, stablecoins) and a consumer crypto wallet used by 1M+…
Defy is building a new generation of blockchain compliance solutions, including crypto wallet security, blockchain services, and anti-money…
Send tokens to those you work with directly in Discord, Slack, Telegram, GitHub and Farcaster as well as over email and to a web3 wallet.
Financials
Total raised
$3.5M
Latest round
Convertible Note
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Convertible Note | 2024 | $3.5M | Details |
People
Todd Smith
Executive Officer, Director
Justin Gelinas
Executive Officer, Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
News
TAHO: $3.5 Million Seed Round Raised To Accelerate Distributed Compute Platform For Expanding AI Workloads
TAHO has secured a $3.5 million seed round to advance development of its distributed compute platform, designed to meet the rapidly expanding demands of artificial intelligence and high-performance computing. The company, founded by veterans of Meta, Goog
Read more
Report
TAHO Pharma Announces Submission of New Drug Application (NDA) to the U.S. FDA for TAH3311 - The World
TAHO Pharmaceuticals Ltd. ("TAHO Pharma") today announced the submission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for TAH3311, the world
Read more
Report
TAHO Pharma Announces Submission of New Drug Application (NDA) to the U.S. FDA for TAH3311 - The World
TAHO Pharmaceuticals Ltd. ("TAHO Pharma") today announced the submission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for TAH3311, the world
Read more
Report
(CNW) TAHO Pharma Announces Submission of New Drug Application (NDA) to the U.S. FDA for TAH3311 - The World's First Apixaban Oral Dissolving Film - Represents a ...
Read more
Report
TAHO Pharmaceuticals Completes Pivotal Trial of TAH3311, the First Oral Dissolving Film Anticoagulant
TAHO Pharmaceuticals is pleased to announce the successful completion of the pivotal trial for TAH3311, the first anticoagulant oral dissolving film (ODF). This trial was conducted following detailed discussions and alignment with the U.S. Food and Drug A
Read more
Report
TAHO Pharmaceuticals Completes Pivotal Trial of TAH3311, the First Oral Dissolving Film Anticoagulant
/PRNewswire/ -- TAHO Pharmaceuticals is pleased to announce the successful completion of the pivotal trial for TAH3311, the first anticoagulant oral dissolving...
Read more
Report
Taho is finally available online!
You can now place an order online for the Pinoy-favorite Taho! Here's a list where you can get them.
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Venice
United States
HQ
10-50 est. staff